Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
TipRanks on MSN
Roche Exercises Option with Recursion Pharmaceuticals
An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...
Just as a proposal to return JavaFX to the Java Development Kit has drawn interest in the OpenJDK community, Oracle too says ...
Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...
Well over a decade has passed since the release of Mojang 's monumental sandbox game Minecraft, with countless mods dropping ...
In the latest close session, Recursion Pharmaceuticals (RXRX) was down 5.42% at $5.23. The stock fell short of the S&P 500, which registered a loss of 0.38% for the day. Meanwhile, the Dow experienced ...
The Jakarta Persistence API (JPA) is a specification that defines a standardized framework for data persistence. Persistence is the fundamental mechanism for saving and retrieving data over time. In ...
Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Recursion Pharmaceuticals (NASDAQ:RXRX), a $2.3 billion market cap biotech company currently trading at $5.31, saw Chief Executive Officer Christopher Gibson sell 100,000 shares of Class A Common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback